John Timmer, Ph.D.

Dr. Timmer leads many aspects of research at Inhibrx, including protein engineering, assay development, and new technologies. He has been instrumental in developing the Inhibrx multi-specific antibody formats for conditional immune activation and generally oversees single domain antibody discovery projects. Prior to joining Inhibrx in 2010, Dr. Timmer completed his postdoctoral training in Jack Dixon’s laboratory in the Department of Pharmacology at UCSD. Dr. Timmer received his Ph.D. from the UCSD Biomedical Sciences Program, performing his thesis research in the laboratory of Guy Salvesen at the Sanford-Burnham-Prebys Medical Discover Institute.